ctrl K

Price Alert

BioCryst Pharmaceuticals ... (BCRX)

NASDAQ: BCRX · Real-Time Price · USD

8.37

-0.08 (-0.95%)

At close: Aug 15, 2025, 3:59 PM

8.37

0.06%

After-hours: Aug 15, 2025, 07:46 PM EDT

BioCryst Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	104.71M	110.64M	304.77M	504.39M
Short-Term Investments	216.14M	278.34M	119.54M	3.21M
Long-Term Investments	20.32M	n/a	18.08M	6.83M
Other Long-Term Assets	28.34M	80K	6.81M	n/a
Receivables	79.07M	56.95M	50.6M	29.41M
Inventory	8.09M	28.68M	27.53M	15.79M
Other Current Assets	13.96M	1.8M	1.47M	3.35M
Total Current Assets	421.97M	495.97M	516.5M	566.14M
Property-Plant & Equipment	19.79M	20.91M	15.42M	15.19M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	68.45M	20.99M	33.5M	22.02M
Total Assets	490.42M	516.96M	550M	588.15M
Account Payables	11.64M	20.89M	14.36M	27.81M
Deferred Revenue	n/a	n/a	1.22M	1.42M
Short-Term Debt	32.68M	23.57M	n/a	n/a
Other Current Liabilities	64.66M	66.36M	65.44M	52M
Total Current Liabilities	160.38M	149.99M	105.51M	103.72M
Long-Term Debt	795.92M	811.26M	733.28M	585.46M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	805.97M	822.5M	739.08M	591.42M
Total Liabilities	966.35M	972.49M	844.6M	695.14M
Total Debt	841.42M	848.71M	741.45M	593.24M
Common Stock	2.08M	2.06M	1.88M	1.84M
Retained Earnings	-1.77B	-1.68B	-1.45B	-1.21B
Comprehensive Income	921K	1.34M	26K	177K
Shareholders Equity	-475.93M	-455.53M	-294.6M	-106.99M
Total Investments	236.46M	278.34M	137.62M	10.04M